Copyright Reports & Markets. All rights reserved.

Global Amantadine HCl Oral Sales Market Report 2021

Request for Sample of this report
Buy now

1 Amantadine HCl Oral Market Overview

  • 1.1 Amantadine HCl Oral Product Scope
  • 1.2 Amantadine HCl Oral Segment by Type
    • 1.2.1 Global Amantadine HCl Oral Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Tablet
    • 1.2.3 Capsules
    • 1.2.4 Syrup
  • 1.3 Amantadine HCl Oral Segment by Application
    • 1.3.1 Global Amantadine HCl Oral Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Parkinson's Disease
    • 1.3.3 Influenza
  • 1.4 Amantadine HCl Oral Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Amantadine HCl Oral Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Amantadine HCl Oral Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Amantadine HCl Oral Price Trends (2016-2027)

2 Amantadine HCl Oral Estimates and Forecasts by Region

  • 2.1 Global Amantadine HCl Oral Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Amantadine HCl Oral Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Amantadine HCl Oral Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Amantadine HCl Oral Revenue Market Share by Region (2016-2021)
  • 2.3 Global Amantadine HCl Oral Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Amantadine HCl Oral Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Amantadine HCl Oral Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Amantadine HCl Oral Estimates and Projections (2016-2027)
    • 2.4.2 Europe Amantadine HCl Oral Estimates and Projections (2016-2027)
    • 2.4.3 China Amantadine HCl Oral Estimates and Projections (2016-2027)
    • 2.4.4 Japan Amantadine HCl Oral Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Amantadine HCl Oral Estimates and Projections (2016-2027)
    • 2.4.6 India Amantadine HCl Oral Estimates and Projections (2016-2027)

3 Global Amantadine HCl Oral Competition Landscape by Players

  • 3.1 Global Top Amantadine HCl Oral Players by Sales (2016-2021)
  • 3.2 Global Top Amantadine HCl Oral Players by Revenue (2016-2021)
  • 3.3 Global Amantadine HCl Oral Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amantadine HCl Oral as of 2020)
  • 3.4 Global Amantadine HCl Oral Average Price by Company (2016-2021)
  • 3.5 Manufacturers Amantadine HCl Oral Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Amantadine HCl Oral Market Size by Type

  • 4.1 Global Amantadine HCl Oral Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Amantadine HCl Oral Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Amantadine HCl Oral Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Amantadine HCl Oral Price by Type (2016-2021)
  • 4.2 Global Amantadine HCl Oral Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Amantadine HCl Oral Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Amantadine HCl Oral Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Amantadine HCl Oral Price Forecast by Type (2022-2027)

5 Global Amantadine HCl Oral Market Size by Application

  • 5.1 Global Amantadine HCl Oral Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Amantadine HCl Oral Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Amantadine HCl Oral Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Amantadine HCl Oral Price by Application (2016-2021)
  • 5.2 Global Amantadine HCl Oral Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Amantadine HCl Oral Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Amantadine HCl Oral Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Amantadine HCl Oral Price Forecast by Application (2022-2027)

6 North America Amantadine HCl Oral Market Facts & Figures

  • 6.1 North America Amantadine HCl Oral Sales by Company
    • 6.1.1 North America Amantadine HCl Oral Sales by Company (2016-2021)
    • 6.1.2 North America Amantadine HCl Oral Revenue by Company (2016-2021)
  • 6.2 North America Amantadine HCl Oral Sales Breakdown by Type
    • 6.2.1 North America Amantadine HCl Oral Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Amantadine HCl Oral Sales Breakdown by Type (2022-2027)
  • 6.3 North America Amantadine HCl Oral Sales Breakdown by Application
    • 6.3.1 North America Amantadine HCl Oral Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Amantadine HCl Oral Sales Breakdown by Application (2022-2027)

7 Europe Amantadine HCl Oral Market Facts & Figures

  • 7.1 Europe Amantadine HCl Oral Sales by Company
    • 7.1.1 Europe Amantadine HCl Oral Sales by Company (2016-2021)
    • 7.1.2 Europe Amantadine HCl Oral Revenue by Company (2016-2021)
  • 7.2 Europe Amantadine HCl Oral Sales Breakdown by Type
    • 7.2.1 Europe Amantadine HCl Oral Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Amantadine HCl Oral Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Amantadine HCl Oral Sales Breakdown by Application
    • 7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)

8 China Amantadine HCl Oral Market Facts & Figures

  • 8.1 China Amantadine HCl Oral Sales by Company
    • 8.1.1 China Amantadine HCl Oral Sales by Company (2016-2021)
    • 8.1.2 China Amantadine HCl Oral Revenue by Company (2016-2021)
  • 8.2 China Amantadine HCl Oral Sales Breakdown by Type
    • 8.2.1 China Amantadine HCl Oral Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Amantadine HCl Oral Sales Breakdown by Type (2022-2027)
  • 8.3 China Amantadine HCl Oral Sales Breakdown by Application
    • 8.3.1 China 165 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 165 Sales Breakdown by Application (2022-2027)

9 Japan Amantadine HCl Oral Market Facts & Figures

  • 9.1 Japan Amantadine HCl Oral Sales by Company
    • 9.1.1 Japan Amantadine HCl Oral Sales by Company (2016-2021)
    • 9.1.2 Japan Amantadine HCl Oral Revenue by Company (2016-2021)
  • 9.2 Japan Amantadine HCl Oral Sales Breakdown by Type
    • 9.2.1 Japan Amantadine HCl Oral Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Amantadine HCl Oral Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Amantadine HCl Oral Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Amantadine HCl Oral Market Facts & Figures

  • 10.1 Southeast Asia Amantadine HCl Oral Sales by Company
    • 10.1.1 Southeast Asia Amantadine HCl Oral Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Amantadine HCl Oral Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Amantadine HCl Oral Sales Breakdown by Type
    • 10.2.1 Southeast Asia Amantadine HCl Oral Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Amantadine HCl Oral Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Amantadine HCl Oral Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Amantadine HCl Oral Market Facts & Figures

  • 11.1 India Amantadine HCl Oral Sales by Company
    • 11.1.1 India Amantadine HCl Oral Sales by Company (2016-2021)
    • 11.1.2 India Amantadine HCl Oral Revenue by Company (2016-2021)
  • 11.2 India Amantadine HCl Oral Sales Breakdown by Type
    • 11.2.1 India Amantadine HCl Oral Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Amantadine HCl Oral Sales Breakdown by Type (2022-2027)
  • 11.3 India Amantadine HCl Oral Sales Breakdown by Application
    • 11.3.1 India Amantadine HCl Oral Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Amantadine HCl Oral Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Amantadine HCl Oral Business

  • 12.1 Zydus Pharmaceuticals
    • 12.1.1 Zydus Pharmaceuticals Corporation Information
    • 12.1.2 Zydus Pharmaceuticals Business Overview
    • 12.1.3 Zydus Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Zydus Pharmaceuticals Amantadine HCl Oral Products Offered
    • 12.1.5 Zydus Pharmaceuticals Recent Development
  • 12.2 Mylan
    • 12.2.1 Mylan Corporation Information
    • 12.2.2 Mylan Business Overview
    • 12.2.3 Mylan Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Mylan Amantadine HCl Oral Products Offered
    • 12.2.5 Mylan Recent Development
  • 12.3 Teva
    • 12.3.1 Teva Corporation Information
    • 12.3.2 Teva Business Overview
    • 12.3.3 Teva Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Teva Amantadine HCl Oral Products Offered
    • 12.3.5 Teva Recent Development
  • 12.4 Vertical Pharmaceuticals
    • 12.4.1 Vertical Pharmaceuticals Corporation Information
    • 12.4.2 Vertical Pharmaceuticals Business Overview
    • 12.4.3 Vertical Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Vertical Pharmaceuticals Amantadine HCl Oral Products Offered
    • 12.4.5 Vertical Pharmaceuticals Recent Development
  • 12.5 Adamas Pharmaceuticals
    • 12.5.1 Adamas Pharmaceuticals Corporation Information
    • 12.5.2 Adamas Pharmaceuticals Business Overview
    • 12.5.3 Adamas Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Adamas Pharmaceuticals Amantadine HCl Oral Products Offered
    • 12.5.5 Adamas Pharmaceuticals Recent Development
  • 12.6 Upsher-Smith
    • 12.6.1 Upsher-Smith Corporation Information
    • 12.6.2 Upsher-Smith Business Overview
    • 12.6.3 Upsher-Smith Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Upsher-Smith Amantadine HCl Oral Products Offered
    • 12.6.5 Upsher-Smith Recent Development
  • 12.7 Sandoz
    • 12.7.1 Sandoz Corporation Information
    • 12.7.2 Sandoz Business Overview
    • 12.7.3 Sandoz Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Sandoz Amantadine HCl Oral Products Offered
    • 12.7.5 Sandoz Recent Development
  • 12.8 Mikart Pharmaceuticals
    • 12.8.1 Mikart Pharmaceuticals Corporation Information
    • 12.8.2 Mikart Pharmaceuticals Business Overview
    • 12.8.3 Mikart Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Mikart Pharmaceuticals Amantadine HCl Oral Products Offered
    • 12.8.5 Mikart Pharmaceuticals Recent Development
  • 12.9 Pharmaceutical Associates, Inc. (PAI)
    • 12.9.1 Pharmaceutical Associates, Inc. (PAI) Corporation Information
    • 12.9.2 Pharmaceutical Associates, Inc. (PAI) Business Overview
    • 12.9.3 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Products Offered
    • 12.9.5 Pharmaceutical Associates, Inc. (PAI) Recent Development
  • 12.10 Wockhardt Bio AG
    • 12.10.1 Wockhardt Bio AG Corporation Information
    • 12.10.2 Wockhardt Bio AG Business Overview
    • 12.10.3 Wockhardt Bio AG Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Wockhardt Bio AG Amantadine HCl Oral Products Offered
    • 12.10.5 Wockhardt Bio AG Recent Development
  • 12.11 CMP Pharma
    • 12.11.1 CMP Pharma Corporation Information
    • 12.11.2 CMP Pharma Business Overview
    • 12.11.3 CMP Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 CMP Pharma Amantadine HCl Oral Products Offered
    • 12.11.5 CMP Pharma Recent Development
  • 12.12 Bionpharma
    • 12.12.1 Bionpharma Corporation Information
    • 12.12.2 Bionpharma Business Overview
    • 12.12.3 Bionpharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Bionpharma Amantadine HCl Oral Products Offered
    • 12.12.5 Bionpharma Recent Development
  • 12.13 Graviti Pharma
    • 12.13.1 Graviti Pharma Corporation Information
    • 12.13.2 Graviti Pharma Business Overview
    • 12.13.3 Graviti Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Graviti Pharma Amantadine HCl Oral Products Offered
    • 12.13.5 Graviti Pharma Recent Development
  • 12.14 Alembic Pharmaceuticals
    • 12.14.1 Alembic Pharmaceuticals Corporation Information
    • 12.14.2 Alembic Pharmaceuticals Business Overview
    • 12.14.3 Alembic Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Alembic Pharmaceuticals Amantadine HCl Oral Products Offered
    • 12.14.5 Alembic Pharmaceuticals Recent Development
  • 12.15 Strides Pharma
    • 12.15.1 Strides Pharma Corporation Information
    • 12.15.2 Strides Pharma Business Overview
    • 12.15.3 Strides Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Strides Pharma Amantadine HCl Oral Products Offered
    • 12.15.5 Strides Pharma Recent Development
  • 12.16 Heritage Pharmaceuticals
    • 12.16.1 Heritage Pharmaceuticals Corporation Information
    • 12.16.2 Heritage Pharmaceuticals Business Overview
    • 12.16.3 Heritage Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 Heritage Pharmaceuticals Amantadine HCl Oral Products Offered
    • 12.16.5 Heritage Pharmaceuticals Recent Development

13 Amantadine HCl Oral Manufacturing Cost Analysis

  • 13.1 Amantadine HCl Oral Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Amantadine HCl Oral
  • 13.4 Amantadine HCl Oral Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Amantadine HCl Oral Distributors List
  • 14.3 Amantadine HCl Oral Customers

15 Market Dynamics

  • 15.1 Amantadine HCl Oral Market Trends
  • 15.2 Amantadine HCl Oral Drivers
  • 15.3 Amantadine HCl Oral Market Challenges
  • 15.4 Amantadine HCl Oral Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Amantadine HCl Oral market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amantadine HCl Oral market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Tablet
    Capsules
    Syrup

    Segment by Application
    Parkinson's Disease
    Influenza

    The Amantadine HCl Oral market is analysed and market size information is provided by regions (countries). Segment by Application, the Amantadine HCl Oral market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Zydus Pharmaceuticals
    Mylan
    Teva
    Vertical Pharmaceuticals
    Adamas Pharmaceuticals
    Upsher-Smith
    Sandoz
    Mikart Pharmaceuticals
    Pharmaceutical Associates, Inc. (PAI)
    Wockhardt Bio AG
    CMP Pharma
    Bionpharma
    Graviti Pharma
    Alembic Pharmaceuticals
    Strides Pharma
    Heritage Pharmaceuticals

    Buy now